TrialAlzheimer's research & therapy2025

Effects of 52 weeks of precuneus rTMS in Alzheimer's disease patients: a randomized trial.

Giacomo Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.